BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25809628)

  • 1. Therapeutic value of black seed oil in methotrexate hepatotoxicity in Egyptian children with acute lymphoblastic leukemia.
    Hagag AA; AbdElaal AM; Elfaragy MS; Hassan SM; Elzamarany EA
    Infect Disord Drug Targets; 2015; 15(1):64-71. PubMed ID: 25809628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective role of black seed oil in doxorubicin-induced cardiac toxicity in children with acute lymphoblastic leukemia.
    Hagag AA; Badraia IM; El-Shehaby WA; Mabrouk MM
    J Oncol Pharm Pract; 2020 Sep; 26(6):1397-1406. PubMed ID: 31964219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ω-3 fatty acids as an adjuvant therapy ameliorates methotrexate-induced hepatotoxicity in children and adolescents with acute lymphoblastic leukemia: A randomized placebo-controlled study.
    Elbarbary NS; Ismail EA; Farahat RK; El-Hamamsy M
    Nutrition; 2016 Jan; 32(1):41-7. PubMed ID: 26421385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Digestive disease in the immunocompromised patient with acute lymphoblastic leukemia. Experience of the IVth Pediatric Clinic--Oncology Department of the Iaşi Sfânta Maria Children's Hospital].
    Moisă SM; Rusu A; Dumitraş S; Burlea M; Miron I
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):356-65. PubMed ID: 19295004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
    Joannon P; Oviedo I; Campbell M; Tordecilla J
    Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [High methotrexate doses in the treatment program for acute lymphoblastic leukemia and lymphosarcoma in children].
    Makhonova LA; Maiakova SA; Kiselev AV; Gordina GA; Balakirev SA; Gavrilova IE; Moiseenko EI; Morozova OV
    Vopr Onkol; 1990; 36(10):1196-200. PubMed ID: 2251813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between oral mucositis and high-dose methotrexate therapy in pediatric acute lymphoblastic leukemia.
    Maiguma T; Hayashi Y; Ueshima S; Kaji H; Egawa T; Chayama K; Morishima T; Kitamura Y; Sendo T; Gomita Y; Teshima D
    Int J Clin Pharmacol Ther; 2008 Nov; 46(11):584-90. PubMed ID: 19000557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocyte concentrations of metabolites or cumulative doses of 6-mercaptopurine and methotrexate do not predict liver changes in children treated for acute lymphoblastic leukemia.
    Halonen P; Mattila J; Mäkipernaa A; Ruuska T; Schmiegelow K
    Pediatr Blood Cancer; 2006 Jun; 46(7):762-6. PubMed ID: 16395677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacoepigenetics in childhood acute lymphoblastic leukemia: involvement of miRNA polymorphisms in hepatotoxicity.
    Gutierrez-Camino A; Umerez M; Santos B; Martin-Guerrero I; García de Andoin N; Sastre A; Navajas A; Astigarraga I; Garcia-Orad A
    Epigenomics; 2018 Apr; 10(4):409-417. PubMed ID: 29569486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate-related neurotoxicity in the treatment of childhood acute lymphoblastic leukemia.
    Shuper A; Stark B; Kornreich L; Cohen IJ; Avrahami G; Yaniv I
    Isr Med Assoc J; 2002 Nov; 4(11):1050-3. PubMed ID: 12489505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring Of High-Dose Methotrexate (Mtx)-Related Toxicity and Mtx Levels in Children with Acute Lymphoblastic Leukemia: A Pilot-Study in Indonesia.
    Sari NM; Rakhmilla LE; Bashari MH; Zazuli Z; Suryawan N; Susanah S; Reniarti L; Raspati H; Supriyadi E; Kaspers GJL; Idjradinata P
    Asian Pac J Cancer Prev; 2021 Jul; 22(7):2025-2031. PubMed ID: 34319023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global methylation in relation to methotrexate-induced oral mucositis in children with acute lymphoblastic leukemia.
    Oosterom N; Griffioen PH; den Hoed MAH; Pieters R; de Jonge R; Tissing WJE; van den Heuvel-Eibrink MM; Heil SG
    PLoS One; 2018; 13(7):e0199574. PubMed ID: 29985926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma homocysteine, methionine and S-adenosylhomocysteine levels following high-dose methotrexate treatment in pediatric patients with acute lymphoblastic leukemia or Burkitt lymphoma: association with hepatotoxicity.
    Kubota M; Nakata R; Adachi S; Watanabe K; Heike T; Takeshita Y; Shima M
    Leuk Lymphoma; 2014 Jul; 55(7):1591-5. PubMed ID: 24090503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia.
    Csordas K; Hegyi M; Eipel OT; Muller J; Erdelyi DJ; Kovacs GT
    Anticancer Drugs; 2013 Feb; 24(2):189-97. PubMed ID: 23187460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum aminotransferase elevation during and following treatment of childhood acute lymphoblastic leukemia.
    Farrow AC; Buchanan GR; Zwiener RJ; Bowman WP; Winick NJ
    J Clin Oncol; 1997 Apr; 15(4):1560-6. PubMed ID: 9193353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profile.
    Sorich MJ; Pottier N; Pei D; Yang W; Kager L; Stocco G; Cheng C; Panetta JC; Pui CH; Relling MV; Cheok MH; Evans WE
    PLoS Med; 2008 Apr; 5(4):e83. PubMed ID: 18416598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrotoxicity due to intermediate-dose methotrexate without rescue in an obese adolescent with acute lymphoblastic leukemia.
    Sauer M; Rydholm N; Piatkowski J; Lewis V; Steiner M
    Pediatr Hematol Oncol; 2002 Mar; 19(2):135-40. PubMed ID: 11881788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic functions of the liver during chemotherapy in children with acute lymphoblastic leukemia.
    Wiela-Hojenska A; Gorczynska E; Orzechowska-Juzwenko K; Golebiowski W; Hurkacz M; Boguslawska-Jaworska J
    Int J Clin Pharmacol Ther; 2001 Jun; 39(6):246-50. PubMed ID: 11430632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms and therapy-related toxicity in children treated for acute lymphoblastic leukemia and non-Hodgkin lymphoma.
    Kantar M; Kosova B; Cetingul N; Gumus S; Toroslu E; Zafer N; Topcuoglu N; Aksoylar S; Cinar M; Tetik A; Eroglu Z
    Leuk Lymphoma; 2009 Jun; 50(6):912-7. PubMed ID: 19391036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ursodeoxycholic acid and vitamin E in the prevention of liver injury from methotrexate in pediatric leukemia.
    Bordbar M; Shakibazad N; Fattahi M; Haghpanah S; Honar N
    Turk J Gastroenterol; 2018 Mar; 29(2):203-209. PubMed ID: 29749328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.